Skip to content
← Back to this collection

PUBLICATIONS · 28453705

Optimal sequencing of ibrutinib, idelalisib, and venetoclax in chronic lymphocytic leukemia: results from a multicenter study of 683 patients.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Ann Oncol
Publication date
2017 May 1
First author
Mato AR

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Ann Oncol. 2017 May 1;28(5):920-921. doi: 10.1093/annonc/mdx103.
    note
    Source null
    related pmid
    28379289
    relationship
    Comment in

Authors and identifiers

  1. name
    Mato AR
    type
    Author
  2. name
    Hill BT
    type
    Author
  3. name
    Lamanna N
    type
    Author
  4. name
    Barr PM
    type
    Author
  5. name
    Ujjani CS
    type
    Author
  6. name
    Brander DM
    type
    Author
  7. name
    Howlett C
    type
    Author
  8. name
    Skarbnik AP
    type
    Author
  9. name
    Cheson BD
    type
    Author
  10. name
    Zent CS
    type
    Author
  11. name
    Pu JJ
    type
    Author
  12. name
    Kiselev P
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Mato AR
    type
    Author
  2. name
    Hill BT
    type
    Author
  3. name
    Lamanna N
    type
    Author
  4. name
    Barr PM
    type
    Author
  5. name
    Ujjani CS
    type
    Author
  6. name
    Brander DM
    type
    Author
  7. name
    Howlett C
    type
    Author
  8. name
    Skarbnik AP
    type
    Author
  9. name
    Cheson BD
    type
    Author
  10. name
    Zent CS
    type
    Author
  11. name
    Pu JJ
    type
    Author
  12. name
    Kiselev P
    type
    Author
bibliography ids
  1. nci-bib-51e38ad831c17774c15d9b09
book metadata
content sha256
9b8b9a1525801e995ac2b305b5515f9d7b9562fa7f054f11889022ce2bbdd463
document type
citation
dois
  1. 10.1093/annonc/mdx031
electronic publication date
display
Source null
precision
missing
year
Source null
evidence scope
bibliographic_metadata_only
id
pubmed:28453705
immutable id
pubmed:28453705@9b8b9a1525801e995ac2b305b5515f9d7b9562fa7f054f11889022ce2bbdd463
journal
abbreviation
Ann Oncol
issn electronic
1569-8041
issn print
0923-7534
issue
5
name
Annals of oncology : official journal of the European Society for Medical Oncology
nlm unique id
9007735
pages
1050-1056
volume
28
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Ann Oncol. 2017 May 1;28(5):920-921. doi: 10.1093/annonc/mdx103.
    note
    Source null
    related pmid
    28379289
    relationship
    Comment in
outcomes validated
false
pmid
28453705
provenance
batch id
1c173f0e18be0c6d461b
provider
NCBI PubMed ESummary
record sha256
cb0d84d9105a69a050633ef824c124294e8094cc41d8b4eacbbc5e4b7b259420
response sha256
27a6f8bb5d49a8d376b07e1b1768913c558986bf73de92cdd65c8f05a5fa1e61
retrieved at
2026-09-09T23:47:25.975513+00:00
publication date
display
2017 May 1
precision
day
year
2017
publication types
  1. Journal Article
  2. Multicenter Study
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/28453705/
title
Optimal sequencing of ibrutinib, idelalisib, and venetoclax in chronic lymphocytic leukemia: results from a multicenter study of 683 patients.

Preserved source evidence · Not medical advice